Plasma Aminothiol Compounds, but Not Serum Tumor Necrosis Factor Receptor II and Soluble Receptor for Advanced Glycation End Products, Are Related to the Cognitive Impairment in Alzheimer’s Disease and Mild Cognitive Impairment Patients

Publisher： Karger

E-ISSN： 1423-0216|14|3-4|163-167

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.14, Iss.3-4, 2007-12, pp. : 163-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

By  

Hormone Research in Paediatrics, Vol. 85, Iss. 5, 2016-03 ,pp. : 291-300

Karger

Access to resources Recommend Favorite

Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?

By  

Neuroimmunomodulation, Vol. 21, Iss. 2-3, 2014-02 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Plasma Advanced Glycation End Products (AGEs), Receptors for AGEs and Their Correlation with Inflammatory Markers in Middle School-Age Children

By  

Hormone Research in Paediatrics, Vol. 80, Iss. 5, 2013-11 ,pp. : 318-327

Karger

Access to resources Recommend Favorite

Hippocampal Estrogen Receptor-Alpha Splice Variant TADDI in the Human Brain in Aging and Alzheimer’s Disease

By  

Neuroendocrinology, Vol. 89, Iss. 2, 2008-09 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 16, Iss. 3, 2009-02 ,pp. : 171-176

Karger

Access to resources Recommend Favorite